Amsurg Corp. (AMSG) Sees Strong Trading Volume
Shares of Amsurg Corp. (NASDAQ:AMSG) saw unusually-strong trading volume on Friday . Approximately 1,357,859 shares were traded during mid-day trading, an increase of 8% from the previous session’s volume of 1,258,325 shares.The stock last traded at $66.84 and had previously closed at $65.40.
Several analysts have recently issued reports on AMSG shares. Jefferies Group reissued a “buy” rating on shares of Amsurg Corp. in a research report on Sunday, July 3rd. Robert W. Baird reissued a “buy” rating on shares of Amsurg Corp. in a research report on Thursday, June 16th. Zacks Investment Research raised shares of Amsurg Corp. from a “hold” rating to a “buy” rating and set a $88.00 price target on the stock in a research report on Monday, July 11th. Goldman Sachs Group Inc. reissued a “buy” rating on shares of Amsurg Corp. in a research report on Friday, June 17th. Finally, Citigroup Inc. lowered shares of Amsurg Corp. from a “buy” rating to a “neutral” rating in a research report on Thursday, June 16th. Four analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The company has an average rating of “Buy” and a consensus target price of $93.91.
The company has a market cap of $3.62 billion and a PE ratio of 19.97. The company has a 50-day moving average price of $69.92 and a 200 day moving average price of $74.02.
Amsurg Corp. (NASDAQ:AMSG) last posted its quarterly earnings data on Tuesday, August 2nd. The company reported $1.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.08 by $0.02. The business earned $758.50 million during the quarter, compared to analysts’ expectations of $769.88 million. The business’s quarterly revenue was up 21.5% compared to the same quarter last year. During the same period in the previous year, the business posted $0.97 EPS. On average, equities research analysts expect that Amsurg Corp. will post $4.33 earnings per share for the current fiscal year.
In related news, insider Robert Jon Coward sold 7,500 shares of the firm’s stock in a transaction that occurred on Friday, August 26th. The shares were sold at an average price of $63.65, for a total value of $477,375.00. Following the transaction, the insider now owns 97,507 shares of the company’s stock, valued at $6,206,320.55. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.
A hedge fund recently raised its stake in Amsurg Corp. stock. Dimensional Fund Advisors LP raised its position in Amsurg Corp. (NASDAQ:AMSG) by 3.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,994,029 shares of the company’s stock after buying an additional 92,088 shares during the period. Dimensional Fund Advisors LP owned 6.27% of Amsurg Corp. worth $227,552,000 as of its most recent SEC filing.
AmSurg Corp. is a surgical center and physician services company. The Company is an owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology, children’s services, emergency medicine and radiology.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.